secwatch.observer — SEC 8-K summary
======================================

Issuer:     WATERS CORP /DE/ (WAT)
CIK:        0001000697
Form:       8-K
Filed at:   2026-01-27T23:59:59+00:00
Accession:  0001193125-26-024492
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 5.07, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Waters shareholders approve BD Biosciences combination; close expected Feb 9, 2026
--------------------------------------------------------------------------------

- Approximately 99% of shares present at special meeting voted to approve share issuance for BD Biosciences deal.
- Transaction expected to close on February 9, 2026, subject to remaining customary conditions.
- IRS private letter ruling on tax consequences received; all required regulatory approvals secured.
- Waters Q4 2025 earnings release and conference call rescheduled to February 9, 2026, in conjunction with close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000697/000119312526024492/0001193125-26-024492-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000697/000119312526024492/d60099d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-024492

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer